Brief: Nextcell Pharma Q1 Operating Loss Widens To SEK 9.8 Mln
25/01/2024 06:39
Jan 25 (Reuters) - NextCell Pharma AB NXTCL.ST :
* NEXTCELL PHARMA AB - Q1 OPERATING RESULT AMOUNTED TO
-9,796
(-8,918) TSEK
Source text for Eikon: ID:nWkr9Bs2cD
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln